Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $5,338 | $11,664 | $19,645 | $24,674 |
| - Cash | $18,179 | $21,055 | $22,837 | $24,399 |
| + Debt | $25,082 | $25,731 | $26,099 | $25,812 |
| Enterprise Value | $12,242 | $16,340 | $22,907 | $26,087 |
| Revenue | $9,162 | $11,200 | $9,161 | $18,817 |
| % Growth | -18.2% | 22.3% | -51.3% | – |
| Gross Profit | $3,553 | $1,541 | $1,075 | $3,593 |
| % Margin | 38.8% | 13.8% | 11.7% | 19.1% |
| EBITDA | $1,508 | -$5,115 | -$5,605 | -$9,761 |
| % Margin | 16.5% | -45.7% | -61.2% | -51.9% |
| Net Income | -$855 | -$6,699 | -$6,946 | -$8,790 |
| % Margin | -9.3% | -59.8% | -75.8% | -46.7% |
| EPS Diluted | -0.035 | -0.26 | -0.23 | -0.29 |
| % Growth | 86.5% | -13% | 20.7% | – |
| Operating Cash Flow | -$2,832 | -$5,060 | -$433 | -$4,369 |
| Capital Expenditures | $29 | -$345 | -$849 | -$287 |
| Free Cash Flow | -$2,803 | -$5,405 | -$1,282 | -$4,656 |